2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
Show more...
執行長
Mr. William D. Baird III, M.B.A.
員工
65
國家
美國
ISIN
US9013841070
上市
0 Comments
分享你的想法
FAQ
2seventy bio 今天的股價是多少?▼
TSVT 目前價格為 $5.00 USD,過去 24 小時上漲了 +0.2%。在圖表上更密切關注 2seventy bio 股價表現。
2seventy bio 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 XNAS 交易所,2seventy bio 的股票以代號 TSVT 進行交易。